| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,391 |
2,675 |
$237K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,153 |
1,677 |
$234K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,881 |
1,934 |
$216K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,613 |
3,278 |
$43K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
815 |
590 |
$35K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
318 |
177 |
$33K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
324 |
210 |
$31K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,776 |
1,182 |
$20K |
| 80053 |
Comprehensive metabolic panel |
3,276 |
2,064 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
512 |
266 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,893 |
2,463 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
2,015 |
1,366 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
261 |
191 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
100 |
36 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
156 |
93 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
389 |
315 |
$6K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
204 |
109 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
726 |
561 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
744 |
547 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
41 |
31 |
$3K |
| 11721 |
|
301 |
163 |
$2K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
182 |
51 |
$2K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
14 |
14 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
81 |
38 |
$1K |
| 83735 |
|
337 |
163 |
$1K |
| 80061 |
Lipid panel |
127 |
115 |
$1K |
| 84484 |
|
217 |
95 |
$864.15 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
45 |
29 |
$797.75 |
| 87899 |
|
72 |
58 |
$552.22 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
276 |
125 |
$484.54 |
| 83605 |
|
92 |
38 |
$439.57 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
130 |
49 |
$379.38 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
103 |
79 |
$339.22 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15 |
13 |
$246.29 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15 |
13 |
$246.29 |
| 86140 |
|
89 |
62 |
$208.58 |
| 69210 |
|
20 |
13 |
$172.81 |
| 81000 |
|
137 |
101 |
$169.32 |
| 81001 |
|
145 |
89 |
$153.21 |
| 81002 |
|
78 |
24 |
$96.20 |
| 87070 |
|
16 |
12 |
$71.36 |
| 81003 |
|
128 |
79 |
$63.77 |
| 87081 |
|
13 |
13 |
$63.24 |
| 99459 |
|
84 |
80 |
$27.62 |
| 94761 |
|
44 |
28 |
$21.20 |
| 85652 |
|
14 |
12 |
$20.12 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
17 |
12 |
$3.00 |
| L4360 |
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
13 |
12 |
$0.00 |